Catalyst Wire Dossier Catalyst Wire Dossier

Mangaciclanol

· GE Healthcare
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mangaciclanol, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients [Phase 2, Phase 3]

See pricing